Tumor microenvironment and angiogenesis
- PMID: 18508679
- DOI: 10.2741/3173
Tumor microenvironment and angiogenesis
Abstract
The tumor microenvironment is a mixture of extracellular matrix molecules, tumor cells, endothelial cells, fibroblasts and immune cells. Tumor growth and metastasis formation are dependent on the growth of blood vessels into the tumor mass. The tumor microenvironment contributes to this pathological angiogenic process. The extracellular matrix and basement membranes are a source for endogenous angiogenesis inhibitors, such as endostatin. On the other hand, many extracellular matrix molecules can promote angiogenesis by stabilizing blood vessels and sequestering pro-angiogenic growth factors. The majority of stromal cells in carcinomas are fibroblasts. Carcinoma-associated fibroblasts show a distinct phenotype from normal fibroblasts. The mechanisms how the tumor-associated fibroblasts regulate angiogenesis are not fully known, but they are suggested to be an important source for growth factors and cytokines recruiting endothelial cells. The immune cells, particularly macrophages and neutrophils are another source for angiogenesis-regulating chemokines, growth factors and proteases. Taken together, the tumor microenvironment is a complex unorganized tissue of various cell types and extracellular matrix that can regulate the pathological angiogenic switch.
Similar articles
-
Role of the tumor microenvironment in mediating response to anti-angiogenic therapy.Cancer Metastasis Rev. 2000;19(1-2):147-57. doi: 10.1023/a:1026510130114. Cancer Metastasis Rev. 2000. PMID: 11191054 Review.
-
Decoding the mechanism of vascular morphogenesis to explore future prospects in targeted tumor therapy.Med Oncol. 2022 Aug 29;39(11):178. doi: 10.1007/s12032-022-01810-z. Med Oncol. 2022. PMID: 36036322 Review.
-
Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. doi: 10.2174/1568011033353452. Curr Med Chem Anticancer Agents. 2003. PMID: 12678905 Review.
-
Havoc in harmony: Unravelling the intricacies of angiogenesis orchestrated by the tumor microenvironment.Cancer Treat Rev. 2024 Jun;127:102749. doi: 10.1016/j.ctrv.2024.102749. Epub 2024 May 1. Cancer Treat Rev. 2024. PMID: 38714074 Review.
-
Microenvironmental regulation of tumour angiogenesis.Nat Rev Cancer. 2017 Aug;17(8):457-474. doi: 10.1038/nrc.2017.51. Epub 2017 Jul 14. Nat Rev Cancer. 2017. PMID: 28706266 Review.
Cited by
-
Maclurin suppresses migration and invasion of human non-small-cell lung cancer cells via anti-oxidative activity and inhibition of the Src/FAK-ERK-β-catenin pathway.Mol Cell Biochem. 2015 Apr;402(1-2):243-52. doi: 10.1007/s11010-015-2331-4. Epub 2015 Jan 29. Mol Cell Biochem. 2015. PMID: 25630491
-
RETRACTED: Collagen prolyl hydroxylases are essential for breast cancer metastasis.Cancer Res. 2013 Jun 1;73(11):3285-96. doi: 10.1158/0008-5472.CAN-12-3963. Epub 2013 Mar 28. Cancer Res. 2013. Retraction in: Cancer Res. 2024 Sep 4;84(17):2927. doi: 10.1158/0008-5472.CAN-24-2214. PMID: 23539444 Free PMC article. Retracted.
-
Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes.Cancer Microenviron. 2012 Dec;5(3):225-36. doi: 10.1007/s12307-012-0106-y. Epub 2012 Apr 20. Cancer Microenviron. 2012. PMID: 22528877 Free PMC article.
-
A PK2/Bv8/PROK2 antagonist suppresses tumorigenic processes by inhibiting angiogenesis in glioma and blocking myeloid cell infiltration in pancreatic cancer.PLoS One. 2013;8(1):e54916. doi: 10.1371/journal.pone.0054916. Epub 2013 Jan 23. PLoS One. 2013. PMID: 23372791 Free PMC article.
-
Insulin promotes proliferative vitality and invasive capability of pancreatic cancer cells via hypoxia-inducible factor 1alpha pathway.J Huazhong Univ Sci Technolog Med Sci. 2010 Jun;30(3):349-53. doi: 10.1007/s11596-010-0355-2. Epub 2010 Jun 17. J Huazhong Univ Sci Technolog Med Sci. 2010. PMID: 20556580
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources